GO:0051435 | BH4 domain binding | 4.85e-04 | 1.00e+00 | 11.009 | 1 | 1 | 1 |
GO:0060795 | cell fate commitment involved in formation of primary germ layer | 4.85e-04 | 1.00e+00 | 11.009 | 1 | 1 | 1 |
GO:0008750 | NAD(P)+ transhydrogenase (AB-specific) activity | 4.85e-04 | 1.00e+00 | 11.009 | 1 | 1 | 1 |
GO:0008746 | NAD(P)+ transhydrogenase activity | 4.85e-04 | 1.00e+00 | 11.009 | 1 | 1 | 1 |
GO:0090308 | regulation of methylation-dependent chromatin silencing | 4.85e-04 | 1.00e+00 | 11.009 | 1 | 1 | 1 |
GO:0090081 | regulation of heart induction by regulation of canonical Wnt signaling pathway | 4.85e-04 | 1.00e+00 | 11.009 | 1 | 1 | 1 |
GO:0023057 | negative regulation of signaling | 4.85e-04 | 1.00e+00 | 11.009 | 1 | 1 | 1 |
GO:0060965 | negative regulation of gene silencing by miRNA | 4.85e-04 | 1.00e+00 | 11.009 | 1 | 1 | 1 |
GO:0003957 | NAD(P)+ transhydrogenase (B-specific) activity | 4.85e-04 | 1.00e+00 | 11.009 | 1 | 1 | 1 |
GO:0072376 | protein activation cascade | 4.85e-04 | 1.00e+00 | 11.009 | 1 | 1 | 1 |
GO:0006366 | transcription from RNA polymerase II promoter | 7.81e-04 | 1.00e+00 | 3.883 | 3 | 30 | 419 |
GO:0009786 | regulation of asymmetric cell division | 9.70e-04 | 1.00e+00 | 10.009 | 1 | 1 | 2 |
GO:0060913 | cardiac cell fate determination | 1.46e-03 | 1.00e+00 | 9.424 | 1 | 1 | 3 |
GO:0003130 | BMP signaling pathway involved in heart induction | 1.46e-03 | 1.00e+00 | 9.424 | 1 | 1 | 3 |
GO:0038127 | ERBB signaling pathway | 1.94e-03 | 1.00e+00 | 9.009 | 1 | 1 | 4 |
GO:0001714 | endodermal cell fate specification | 2.42e-03 | 1.00e+00 | 8.687 | 1 | 1 | 5 |
GO:0016607 | nuclear speck | 2.85e-03 | 1.00e+00 | 4.582 | 2 | 12 | 172 |
GO:0061099 | negative regulation of protein tyrosine kinase activity | 3.39e-03 | 1.00e+00 | 8.201 | 1 | 1 | 7 |
GO:0007172 | signal complex assembly | 3.88e-03 | 1.00e+00 | 8.009 | 1 | 1 | 8 |
GO:0060396 | growth hormone receptor signaling pathway | 3.88e-03 | 1.00e+00 | 8.009 | 1 | 1 | 8 |
GO:0031953 | negative regulation of protein autophosphorylation | 4.36e-03 | 1.00e+00 | 7.839 | 1 | 1 | 9 |
GO:0035413 | positive regulation of catenin import into nucleus | 4.84e-03 | 1.00e+00 | 7.687 | 1 | 2 | 10 |
GO:0008380 | RNA splicing | 4.96e-03 | 1.00e+00 | 4.176 | 2 | 22 | 228 |
GO:0017166 | vinculin binding | 5.33e-03 | 1.00e+00 | 7.549 | 1 | 1 | 11 |
GO:0005746 | mitochondrial respiratory chain | 5.33e-03 | 1.00e+00 | 7.549 | 1 | 1 | 11 |
GO:0060391 | positive regulation of SMAD protein import into nucleus | 5.33e-03 | 1.00e+00 | 7.549 | 1 | 4 | 11 |
GO:0035198 | miRNA binding | 5.81e-03 | 1.00e+00 | 7.424 | 1 | 1 | 12 |
GO:0042789 | mRNA transcription from RNA polymerase II promoter | 6.29e-03 | 1.00e+00 | 7.308 | 1 | 2 | 13 |
GO:0005685 | U1 snRNP | 6.78e-03 | 1.00e+00 | 7.201 | 1 | 1 | 14 |
GO:0034614 | cellular response to reactive oxygen species | 6.78e-03 | 1.00e+00 | 7.201 | 1 | 2 | 14 |
GO:0006376 | mRNA splice site selection | 7.26e-03 | 1.00e+00 | 7.102 | 1 | 1 | 15 |
GO:0001824 | blastocyst development | 7.26e-03 | 1.00e+00 | 7.102 | 1 | 2 | 15 |
GO:0043274 | phospholipase binding | 7.74e-03 | 1.00e+00 | 7.009 | 1 | 1 | 16 |
GO:0019901 | protein kinase binding | 9.40e-03 | 1.00e+00 | 3.700 | 2 | 18 | 317 |
GO:0048041 | focal adhesion assembly | 1.01e-02 | 1.00e+00 | 6.616 | 1 | 1 | 21 |
GO:0044822 | poly(A) RNA binding | 1.10e-02 | 1.00e+00 | 2.549 | 3 | 50 | 1056 |
GO:0005925 | focal adhesion | 1.24e-02 | 1.00e+00 | 3.493 | 2 | 9 | 366 |
GO:0048754 | branching morphogenesis of an epithelial tube | 1.30e-02 | 1.00e+00 | 6.254 | 1 | 1 | 27 |
GO:0050661 | NADP binding | 1.30e-02 | 1.00e+00 | 6.254 | 1 | 1 | 27 |
GO:0005875 | microtubule associated complex | 1.35e-02 | 1.00e+00 | 6.201 | 1 | 1 | 28 |
GO:0006099 | tricarboxylic acid cycle | 1.35e-02 | 1.00e+00 | 6.201 | 1 | 1 | 28 |
GO:0030032 | lamellipodium assembly | 1.40e-02 | 1.00e+00 | 6.151 | 1 | 1 | 29 |
GO:0015992 | proton transport | 1.40e-02 | 1.00e+00 | 6.151 | 1 | 1 | 29 |
GO:0072593 | reactive oxygen species metabolic process | 1.50e-02 | 1.00e+00 | 6.055 | 1 | 2 | 31 |
GO:0051287 | NAD binding | 1.54e-02 | 1.00e+00 | 6.009 | 1 | 2 | 32 |
GO:0001104 | RNA polymerase II transcription cofactor activity | 1.59e-02 | 1.00e+00 | 5.964 | 1 | 8 | 33 |
GO:0016592 | mediator complex | 1.69e-02 | 1.00e+00 | 5.879 | 1 | 10 | 35 |
GO:0034446 | substrate adhesion-dependent cell spreading | 1.73e-02 | 1.00e+00 | 5.839 | 1 | 2 | 36 |
GO:0035019 | somatic stem cell maintenance | 1.93e-02 | 1.00e+00 | 5.687 | 1 | 6 | 40 |
GO:0031124 | mRNA 3'-end processing | 2.02e-02 | 1.00e+00 | 5.616 | 1 | 2 | 42 |
GO:1902600 | hydrogen ion transmembrane transport | 2.07e-02 | 1.00e+00 | 5.582 | 1 | 2 | 43 |
GO:0006369 | termination of RNA polymerase II transcription | 2.16e-02 | 1.00e+00 | 5.517 | 1 | 2 | 45 |
GO:0009611 | response to wounding | 2.50e-02 | 1.00e+00 | 5.308 | 1 | 5 | 52 |
GO:0051028 | mRNA transport | 2.50e-02 | 1.00e+00 | 5.308 | 1 | 4 | 52 |
GO:0001725 | stress fiber | 2.64e-02 | 1.00e+00 | 5.227 | 1 | 4 | 55 |
GO:0005643 | nuclear pore | 2.73e-02 | 1.00e+00 | 5.176 | 1 | 11 | 57 |
GO:0008013 | beta-catenin binding | 2.88e-02 | 1.00e+00 | 5.102 | 1 | 9 | 60 |
GO:0006406 | mRNA export from nucleus | 2.92e-02 | 1.00e+00 | 5.078 | 1 | 4 | 61 |
GO:0019903 | protein phosphatase binding | 2.97e-02 | 1.00e+00 | 5.055 | 1 | 2 | 62 |
GO:0010468 | regulation of gene expression | 3.25e-02 | 1.00e+00 | 4.921 | 1 | 2 | 68 |
GO:0034329 | cell junction assembly | 3.25e-02 | 1.00e+00 | 4.921 | 1 | 3 | 68 |
GO:0003729 | mRNA binding | 3.44e-02 | 1.00e+00 | 4.839 | 1 | 4 | 72 |
GO:0000981 | sequence-specific DNA binding RNA polymerase II transcription factor activity | 3.54e-02 | 1.00e+00 | 4.799 | 1 | 4 | 74 |
GO:0005634 | nucleus | 3.60e-02 | 1.00e+00 | 1.176 | 5 | 159 | 4559 |
GO:0007229 | integrin-mediated signaling pathway | 3.73e-02 | 1.00e+00 | 4.723 | 1 | 3 | 78 |
GO:0009653 | anatomical structure morphogenesis | 3.96e-02 | 1.00e+00 | 4.634 | 1 | 2 | 83 |
GO:0006936 | muscle contraction | 4.15e-02 | 1.00e+00 | 4.566 | 1 | 3 | 87 |
GO:0000187 | activation of MAPK activity | 4.29e-02 | 1.00e+00 | 4.517 | 1 | 3 | 90 |
GO:0007010 | cytoskeleton organization | 4.33e-02 | 1.00e+00 | 4.501 | 1 | 4 | 91 |
GO:0006928 | cellular component movement | 4.33e-02 | 1.00e+00 | 4.501 | 1 | 3 | 91 |
GO:0005178 | integrin binding | 4.57e-02 | 1.00e+00 | 4.424 | 1 | 4 | 96 |
GO:0008360 | regulation of cell shape | 4.89e-02 | 1.00e+00 | 4.322 | 1 | 4 | 103 |
GO:0005938 | cell cortex | 4.94e-02 | 1.00e+00 | 4.308 | 1 | 5 | 104 |
GO:0030529 | ribonucleoprotein complex | 5.31e-02 | 1.00e+00 | 4.201 | 1 | 5 | 112 |
GO:0044237 | cellular metabolic process | 5.54e-02 | 1.00e+00 | 4.138 | 1 | 2 | 117 |
GO:0030027 | lamellipodium | 5.91e-02 | 1.00e+00 | 4.043 | 1 | 7 | 125 |
GO:0007179 | transforming growth factor beta receptor signaling pathway | 6.05e-02 | 1.00e+00 | 4.009 | 1 | 11 | 128 |
GO:0018108 | peptidyl-tyrosine phosphorylation | 6.23e-02 | 1.00e+00 | 3.964 | 1 | 4 | 132 |
GO:0000398 | mRNA splicing, via spliceosome | 7.69e-02 | 1.00e+00 | 3.651 | 1 | 15 | 164 |
GO:0044212 | transcription regulatory region DNA binding | 7.88e-02 | 1.00e+00 | 3.616 | 1 | 17 | 168 |
GO:0005737 | cytoplasm | 8.13e-02 | 1.00e+00 | 1.130 | 4 | 124 | 3767 |
GO:0005667 | transcription factor complex | 8.19e-02 | 1.00e+00 | 3.558 | 1 | 17 | 175 |
GO:0031625 | ubiquitin protein ligase binding | 8.33e-02 | 1.00e+00 | 3.533 | 1 | 5 | 178 |
GO:0007173 | epidermal growth factor receptor signaling pathway | 8.82e-02 | 1.00e+00 | 3.446 | 1 | 5 | 189 |
GO:0005654 | nucleoplasm | 9.17e-02 | 1.00e+00 | 1.929 | 2 | 64 | 1082 |
GO:0008134 | transcription factor binding | 1.12e-01 | 1.00e+00 | 3.090 | 1 | 18 | 242 |
GO:0003677 | DNA binding | 1.13e-01 | 1.00e+00 | 1.758 | 2 | 49 | 1218 |
GO:0005515 | protein binding | 1.14e-01 | 1.00e+00 | 0.774 | 5 | 198 | 6024 |
GO:0000166 | nucleotide binding | 1.19e-01 | 1.00e+00 | 2.992 | 1 | 13 | 259 |
GO:0006357 | regulation of transcription from RNA polymerase II promoter | 1.21e-01 | 1.00e+00 | 2.964 | 1 | 23 | 264 |
GO:0005743 | mitochondrial inner membrane | 1.27e-01 | 1.00e+00 | 2.895 | 1 | 6 | 277 |
GO:0005856 | cytoskeleton | 1.33e-01 | 1.00e+00 | 2.824 | 1 | 9 | 291 |
GO:0008283 | cell proliferation | 1.49e-01 | 1.00e+00 | 2.651 | 1 | 14 | 328 |
GO:0015031 | protein transport | 1.54e-01 | 1.00e+00 | 2.595 | 1 | 11 | 341 |
GO:0003723 | RNA binding | 1.55e-01 | 1.00e+00 | 2.591 | 1 | 18 | 342 |
GO:0043565 | sequence-specific DNA binding | 1.56e-01 | 1.00e+00 | 2.574 | 1 | 11 | 346 |
GO:0007155 | cell adhesion | 1.66e-01 | 1.00e+00 | 2.481 | 1 | 5 | 369 |
GO:0005730 | nucleolus | 1.85e-01 | 1.00e+00 | 1.328 | 2 | 66 | 1641 |
GO:0055114 | oxidation-reduction process | 1.87e-01 | 1.00e+00 | 2.294 | 1 | 10 | 420 |
GO:0016020 | membrane | 1.92e-01 | 1.00e+00 | 1.294 | 2 | 46 | 1681 |
GO:0048471 | perinuclear region of cytoplasm | 2.20e-01 | 1.00e+00 | 2.037 | 1 | 8 | 502 |
GO:0010467 | gene expression | 2.83e-01 | 1.00e+00 | 1.623 | 1 | 45 | 669 |
GO:0003700 | sequence-specific DNA binding transcription factor activity | 2.94e-01 | 1.00e+00 | 1.560 | 1 | 39 | 699 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 3.26e-01 | 1.00e+00 | 1.385 | 1 | 41 | 789 |
GO:0007165 | signal transduction | 3.65e-01 | 1.00e+00 | 1.184 | 1 | 13 | 907 |
GO:0005886 | plasma membrane | 3.65e-01 | 1.00e+00 | 0.674 | 2 | 49 | 2582 |
GO:0006355 | regulation of transcription, DNA-templated | 3.94e-01 | 1.00e+00 | 1.047 | 1 | 43 | 997 |
GO:0008270 | zinc ion binding | 3.94e-01 | 1.00e+00 | 1.047 | 1 | 27 | 997 |
GO:0005739 | mitochondrion | 3.95e-01 | 1.00e+00 | 1.046 | 1 | 23 | 998 |
GO:0044281 | small molecule metabolic process | 4.59e-01 | 1.00e+00 | 0.767 | 1 | 20 | 1211 |
GO:0016021 | integral component of membrane | 6.45e-01 | 1.00e+00 | 0.056 | 1 | 17 | 1982 |
GO:0070062 | extracellular vesicular exosome | 7.20e-01 | 1.00e+00 | -0.220 | 1 | 57 | 2400 |
GO:0005829 | cytosol | 7.36e-01 | 1.00e+00 | -0.277 | 1 | 86 | 2496 |